Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICS/LABA reliever therapy versus SABA-based regimens in adults with asthma
2015-002384-42Phase 3Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Aug 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in asthma comparing ICS/LABA reliever therapy, SABA reliever therapy and Maintenance ICS plus SABA reliever therapy (3 arms). Primary endpoint: Asthma exacerbation rate. Started Aug 2016; status: completed.
02
Drugs
budesonidesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-002384-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002384-42.